Surveillance For Low-risk Cancer Research Articles

Active Surveillance vs. Initial Treatment for Low-Risk Prostate Cancer

Since prostate-specific antigen (PSA) was introduced into clinical practice in the late 1980s, PSA-based screening has become ubiquitous in the U.S.